Clinical Trial Update: Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dexlansoprazole MR for heartburn control in GERD patients previously on twice-daily PPI therapy. The study has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Dexlansoprazole MR (dexlansoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux | Phase 3 | Status: COMPLETED | Results posted: 2011-04-29